Clinical trial

NOX-E36 First-in-Human (FIH) Study

NCT00976729

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-05-01

PhasePHASE1

Study timeline

Study start (unknown)2009-05-01Date precision: month

Registry last updated2013-02-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Inflammatory Diseasesunresolved

Type 2 Diabetes Mellitusunresolved

Systemic Lupus Erythematosusunresolved

Interventions

NOX-E36DRUG

PlaceboDRUG

Sponsors & collaborators

TME Pharma AGlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00976729 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.